Carisma Therapeutics, Inc. (CARM)

Carisma Therapeutics Statistics

Total Valuation

CARM has a market cap or net worth of $9.86 million. The enterprise value is $9.29 million.

Market Cap	9.86M
Enterprise Value	9.29M

Important Dates

The last earnings date was Thursday, August 7, 2025, after market close.

Earnings Date	Aug 7, 2025
Ex-Dividend Date	n/a

Share Statistics

CARM has 41.79 million shares outstanding. The number of shares has increased by 2.15% in one year.

Current Share Class	41.79M
Shares Outstanding	41.79M
Shares Change (YoY)	+2.15%
Shares Change (QoQ)	+0.04%
Owned by Insiders (%)	11.99%
Owned by Institutions (%)	15.39%
Float	31.26M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	0.89
Forward PS	1.25
PB Ratio	n/a
P/TBV Ratio	n/a
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	0.86
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 0.48

Current Ratio	0.48
Quick Ratio	0.29
Debt / Equity	n/a
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	n/a

Financial Efficiency

Return on Equity (ROE)	n/a
Return on Assets (ROA)	-85.68%
Return on Invested Capital (ROIC)	n/a
Return on Capital Employed (ROCE)	1,120.14%
Revenue Per Employee	$234,065
Profits Per Employee	-$1.07M
Employee Count	46
Asset Turnover	0.33
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -81.38% in the last 52 weeks. The beta is 3.71, so CARM's price volatility has been higher than the market average.

Beta (5Y)	3.71
52-Week Price Change	-81.38%
50-Day Moving Average	0.37
200-Day Moving Average	0.43
Relative Strength Index (RSI)	30.75
Average Volume (20 Days)	443,109

Short Selling Information

The latest short interest is 428,014, so 1.02% of the outstanding shares have been sold short.

Short Interest	428,014
Short Previous Month	576,389
Short % of Shares Out	1.02%
Short % of Float	1.37%
Short Ratio (days to cover)	0.62

Income Statement

In the last 12 months, CARM had revenue of $10.77 million and -$49.38 million in losses. Loss per share was -$1.18.

Revenue	10.77M
Gross Profit	-27.72M
Operating Income	-44.11M
Pretax Income	-72.70M
Net Income	-49.38M
EBITDA	-42.04M
EBIT	-44.11M
Loss Per Share	-$1.18

Balance Sheet

The company has $2.00 million in cash and $1.70 million in debt, giving a net cash position of $299,000 or $0.01 per share.

Cash & Cash Equivalents	2.00M
Total Debt	1.70M
Net Cash	299,000
Net Cash Per Share	$0.01
Equity (Book Value)	-46.01M
Book Value Per Share	-1.10
Working Capital	-4.66M

Cash Flow

Operating Cash Flow	-37.34M
Capital Expenditures	n/a
Free Cash Flow	-37.34M
FCF Per Share	-$0.89

Margins

Gross Margin	-257.43%
Operating Margin	-409.69%
Pretax Margin	-458.60%
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

CARM does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-2.15%
Shareholder Yield	-2.15%
Earnings Yield	-514.86%
FCF Yield	-389.38%

Analyst Forecast

The average price target for CARM is $0.90, which is 281.36% higher than the current price. The consensus rating is "Hold".

Price Target	$0.90
Price Target Difference	281.36%
Analyst Consensus	Hold
Analyst Count	5
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	-21.73%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

CARM has an Altman Z-Score of -118.36 and a Piotroski F-Score of 2. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	-118.36
Piotroski F-Score	2